Insights from 2025 ASCO® GI Annual Meeting
Video Player is loading.
10 seconds
Playback speed
ASCO® GI 2025 Insights: Adagrasib + Cetuximab for KRAS G12C-Mutated mCRC - KRYSTAL-1 Trial Longer Follow-Up Analysis
By
Insights from 2025 ASCO® GI Annual Meeting
FEATURING
Rona Yaeger
By
Insights from 2025 ASCO® GI Annual Meeting
FEATURING
Rona Yaeger
Comments 0
Login to view comments.
Click here to Login
